and hefty multiple (EV/EBIT c20) ...dyor/no advice intended
6 Sep '13
but still ridin
13 Mar '13
on free ride here now
but still like rel low multiples all opinion only GL all
25 Feb '13
Up and up
Great run from this share. Huge P/e ratio so its outperforming somewhat. think the market is excited with the share buy back. The exercise last time went well and certainly rewarded those of us who didnt tender shares and stayed in
22 Feb '13
CSR: UBS raises target price from 330p to 450p, while retaining a neutral rating. Deutsche Bank revises target price from 255p to 300p, while staying with its sell recommendation.
22 Feb '13
The question now is what CSR does with its strong cash-flow. The last big deal, the $233m purchase of Zoran, was in mid-2011, and though there is probably the odd technology concern the company would not mind picking up, there is no sign of another such on the horizon. Since it started buying back shares in 2010, the company has returned $416.4m before the latest exercise. Yet it had $333m in the bank at the year end. CSR says it will review the situation once the latest buyback is completed. The reckoning must be that more will be returned. The shares have had a good run; on about 15 times earnings they look like good long-term value, but no reason to chase for now. Buy on the (inevitable) weakness, says The Times's Tempus.
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.